BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2734419
Number of visits today
984
Number of downloads
2005246
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Zhao H, Danli S, Qian Z, Ye S, Chen J, Tang Z. Identifying GNG4 might play an important role in colorectal cancer TMB. Cancer Biomark 2021. [PMID: 34275892 DOI: 10.3233/CBM-203009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang G, Hou Y. Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis. World J Surg Onc 2022;20:364. [DOI: 10.1186/s12957-022-02828-3] [Reference Citation Analysis]
2 Danyu Chen, Zhen Ye, Zhenxian Lew, Simin Luo, Zhong Yu, Ying Lin. Expression of NMU, PPBP and GNG4 in colon cancer and their influences on prognosis. Transl Cancer Res 2022;11. [PMID: 36388046 DOI: 10.21037/tcr-22-1377] [Reference Citation Analysis]
3 Vastrad B, Vastrad C. Identification of hub genes and key pathways in pediatric Crohn’s disease using next generation sequencing and bioinformatics analysis.. [DOI: 10.1101/2022.07.27.501664] [Reference Citation Analysis]
4 Duan L, Liu X, Luo Z, Zhang C, Wu C, Mu W, Zuo Z, Pei X, Shao T. G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer. Genes 2022;13:693. [DOI: 10.3390/genes13040693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhou B, Zhu W, Yuan S, Wang Y, Zhang Q, Zheng H, Zhu L, Xu J. High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma. Thoracic Cancer. [DOI: 10.1111/1759-7714.14265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345